Genopathy
Gene-Disorder Association · Article
Gene
KCND3
Potassium Voltage-Gated Channel Subfamily D Member 3
Manually curatedApproved treatment annotated
Association Review

In brief

The association between KCND3 (Potassium Voltage-Gated Channel Subfamily D Member 3) and Atrial Fibrillation is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 3
Compounds 2
Trials 45of 49 via KCND3 compounds
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
KCND3

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Atrial Fibrillation

The disorder

6 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Population genetics

GWAS signals

1 GWAS phenotype

Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.

Request access
06
Interventions

Therapeutics

2 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

49 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Provenance

References & sources

7 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access